Johnson & Johnson to sell LifeScan to Platinum Equity for $2.1B

Johnson & Johnson accepted a binding offer from Platinum Equity to acquire its LifeScan business for approximately $2.1 billion. LifeScan is a blood glucose monitoring company and maker of OneTouch products.

“Johnson and Johnson has accepted the binding offer from Platinum Equity, previously announced on March 16, 2018, to acquire its LifeScan business for approximately USD 2.1 billion.”medicalbuyer.co.in

• 1 source
• medicalbuyer.co.inJ&J accepts binding offer from Platinum Equity to acquire LifeScan - Medical BuyerRitesh KumarJul 13, 2018

Summarized from public sources; check the original articles before acting on it.